Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells.

Autor: Lamb DJ; Immunology & Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riß, Germany., Rust A; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Rudisch A; Cancer Cell Signalling, Boehringer Ingelheim RCV GmbH & Co KG, A-1121 Vienna, Austria., Glüxam T; Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, 1090 Wien, Austria., Harrer N; Cancer Cell Signalling, Boehringer Ingelheim RCV GmbH & Co KG, A-1121 Vienna, Austria., Machat H; Cancer Cell Signalling, Boehringer Ingelheim RCV GmbH & Co KG, A-1121 Vienna, Austria., Christ I; Immunology & Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riß, Germany., Colbatzky F; Non-clinical drug safety, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riß, Germany., Wernitznig A; Cancer Cell Signalling, Boehringer Ingelheim RCV GmbH & Co KG, A-1121 Vienna, Austria., Osswald A; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riß, Germany., Sommergruber W; Cancer Cell Signalling, Boehringer Ingelheim RCV GmbH & Co KG, A-1121 Vienna, Austria.; Biotechnology, University of Applied Sciences, 1030 Vienna, Austria.

Publikováno v: Oncotarget [Oncotarget] 2020 Apr 07; Vol. 11 (14), pp. 1257-1272. Date of Electronic Publication: 2020 Apr 07 (Print Publication: 2020).

First-in-class ruthenium anticancer drug (KP1339/IT-139) induces an immunogenic cell death signature in colorectal spheroids in vitro.

Autor: Wernitznig D; Department of Inorganic Chemistry and Research Cluster 'Translational Cancer Therapy Research', Faculty of Chemistry, University of Vienna, Währinger Straße 42, 1090, Vienna, Austria. debora.wernitznig@univie.ac.at., Kiakos K, Del Favero G, Harrer N, Machat H, Osswald A, Jakupec MA, Wernitznig A, Sommergruber W, Keppler BK

Publikováno v: Metallomics : integrated biometal science [Metallomics] 2019 Jun 19; Vol. 11 (6), pp. 1044-1048.

Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections.

Autor: D'Amato, Assunta¹ (AUTHOR) asdamato@unisa.it, Mariconda, Annaluisa² (AUTHOR) annaluisa.mariconda@unibas.it, Iacopetta, Domenico³ (AUTHOR) domenico.iacopetta@unical.it, Ceramella, Jessica³ (AUTHOR) jessica.ceramella@unical.it, Catalano, Alessia⁴ (AUTHOR) alessia.catalano@uniba.it, Sinicropi, Maria Stefania³ (AUTHOR) s.sinicropi@unical.it, Longo, Pasquale¹ (AUTHOR) plongo@unisa.it

Publikováno v: Pharmaceuticals (14248247). Dec2023, Vol. 16 Issue 12, p1729. 32p.

Integrating Suspended Sludge and Fixed Film into a Biological Wastewater Treatment System to Enhance Nitrogen Removal.

Autor: Bui, Quang Chi, Phan, Nguyen Nguyet Minh, Nguyen, Trung Viet, Yang, Chih-Chi, Chen, Ku-Fan, Tsai, Yung-Pin

Publikováno v: Processes; Oct2024, Vol. 12 Issue 10, p2131, 12p

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds.

Autor: Amiri, Mina¹ (AUTHOR), Molavi, Ommoleila¹ (AUTHOR), Sabetkam, Shahnaz^2,3 (AUTHOR), Jafari, Sevda⁴ (AUTHOR) Jafarise@tbzmed.ac.ir, Montazersaheb, Soheila⁵ (AUTHOR) montazersahebs@tbzmed.ac.ir

Publikováno v: Cancer Cell International. 9/13/2023, Vol. 23 Issue 1, p1-19. 19p.